Skip to main content
Topics
Video
Provider
Payer
Pharma
ANZ
ASIA
EMEA
Global Edition
chemotherapy
Portal Access secures $7M for chemotherapy port
By
Anthony Vecchione
|
04:08 pm |
May 30, 2025
The company will use the funds to support a 510(k) submission to the FDA for its Flexi-Port SLF-TANL for oncology patients.